Avax Technologies Inc

AVAX Technologies, Inc. develops and commercializes individualized therapies and other novel technologies primarily focused on cancer and other life-threatening diseases. The Company's lead development program is the AC Vaccine, which attempts to stimulate the patient's own immune system to recognize, contain, and eliminate cancer cells.